Application 040416
- Type
- ANDA
- Sponsor
- UPSHER SMITH LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 1MG | No | No |
| 002 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 2MG | No | No |
| 003 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 2.5MG | No | No |
| 004 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 3MG | No | No |
| 005 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 4MG | No | No |
| 006 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 5MG | No | No |
| 007 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 6MG | No | No |
| 008 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 7.5MG | No | No |
| 009 | JANTOVEN | WARFARIN SODIUM | TABLET;ORAL | 10MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040416-001 | JANTOVEN | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2003-10-02 | |
| A040416-002 | JANTOVEN | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2003-10-02 | |
| A040416-003 | JANTOVEN | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2003-10-02 | |
| A040416-004 | JANTOVEN | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2003-10-02 | |
| A040416-005 | JANTOVEN | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2003-10-02 | |
| A040416-006 | JANTOVEN | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2003-10-02 | |
| A040416-007 | JANTOVEN | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2003-10-02 | |
| A040416-008 | JANTOVEN | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2003-10-02 | |
| A040416-009 | JANTOVEN | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2003-10-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040416-001 | AB |
| A040416-002 | AB |
| A040416-003 | AB |
| A040416-004 | AB |
| A040416-005 | AB |
| A040416-006 | AB |
| A040416-007 | AB |
| A040416-008 | AB |
| A040416-009 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A040416-001 | JANTOVEN | 1MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A040416-002 | JANTOVEN | 2MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A040416-003 | JANTOVEN | 2.5MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A040416-004 | JANTOVEN | 3MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A040416-005 | JANTOVEN | 4MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A040416-006 | JANTOVEN | 5MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A040416-007 | JANTOVEN | 6MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A040416-008 | JANTOVEN | 7.5MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A040416-009 | JANTOVEN | 10MG | TABLET / ORAL | AB | 2003-10-02 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-001 | JANTOVEN | 1MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-002 | JANTOVEN | 2MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-003 | JANTOVEN | 2.5MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-004 | JANTOVEN | 3MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-005 | JANTOVEN | 4MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-006 | JANTOVEN | 5MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-007 | JANTOVEN | 6MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-008 | JANTOVEN | 7.5MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040416-009 | JANTOVEN | 10MG | TABLET / ORAL | AB | 2003-10-02 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-001 | JANTOVEN | 1MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-002 | JANTOVEN | 2MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-003 | JANTOVEN | 2.5MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-004 | JANTOVEN | 3MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-005 | JANTOVEN | 4MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-006 | JANTOVEN | 5MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-007 | JANTOVEN | 6MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-008 | JANTOVEN | 7.5MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040416-009 | JANTOVEN | 10MG | TABLET / ORAL | AB | 2003-10-02 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-001 | JANTOVEN | 1MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-002 | JANTOVEN | 2MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-003 | JANTOVEN | 2.5MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-004 | JANTOVEN | 3MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-005 | JANTOVEN | 4MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-006 | JANTOVEN | 5MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-007 | JANTOVEN | 6MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-008 | JANTOVEN | 7.5MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040416-009 | JANTOVEN | 10MG | TABLET / ORAL | AB | 2003-10-02 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040416-001 | JANTOVEN | 1MG | TABLET / ORAL | AB | 2003-10-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040416-002 | JANTOVEN | 2MG | TABLET / ORAL | AB | 2003-10-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040416-003 | JANTOVEN | 2.5MG | TABLET / ORAL | AB | 2003-10-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040416-004 | JANTOVEN | 3MG | TABLET / ORAL | AB | 2003-10-02 | 011fe1cb6892… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A040416-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A040416-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A040416-003 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A040416-004 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A040416-005 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A040416-006 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A040416-007 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A040416-008 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A040416-009 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-003 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-004 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-005 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-006 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-007 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-008 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040416-009 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-004 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-005 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-006 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-007 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-008 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040416-009 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-006 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-007 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-008 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040416-009 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A040416-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A040416-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A040416-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A040416-004 | AB | 1 | 011fe1cb6892… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | 8eae6b6c-1851-4342-b320-7e1896894658 | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | a1860448-d4ef-40f2-b096-056429ca3aea | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | d166f83b-7052-4dc7-b7d4-47faae7dcaed | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | e7f78a33-71eb-4aac-ba9d-70f75136fab0 | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | 694e258d-86bd-440c-870b-a7d27fb1c467 | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | PD-Rx Pharmaceuticals, Inc. | 21255cd5-3c2e-4574-9620-9347d14256b3 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | 4f8afe14-897c-458b-b76f-9bae6fa6110e | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | 44077bb7-6007-4c15-bbcd-a7a02ac081ce | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | 7f604dc4-c2cd-4b1f-b94d-b5877a1be66b | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Golden State Medical Supply, Inc. | ba8b4ead-d080-91e7-e053-2995a90a82fe | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Teva Pharmaceuticals USA, Inc. | 0cbce382-9c88-4f58-ae0f-532a841e8f95 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| WARFARIN SODIUM | WARFARIN SODIUM | Direct_Rx | efded00a-22b9-1da7-e053-2995a90a58ca | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| WARFARIN SODIUM | WARFARIN SODIUM | DIRECT RX | c186d1ff-64dd-bfcb-e053-2a95a90af800 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | A-S Medication Solutions | 53a6947e-ef3f-403b-9ccc-1740ae5efad0 | 2024-12-24 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | American Health Packaging | ab047628-67d0-4a64-8d77-36b054969b44 | 2024-10-04 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | American Health Packaging | feaa5f6f-9753-4f37-ab81-04c9c6b45e6a | 2024-10-04 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | A-S Medication Solutions | 5a7d347b-391e-4e9b-a691-1962c7da4fc7 | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | A-S Medication Solutions | 35bf53df-994b-4c32-8bdb-9227e8e195c6 | 2023-08-30 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Proficient Rx LP | 388bfa49-f4f7-412a-80ff-d09442489e2b | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
| Warfarin Sodium | WARFARIN SODIUM | Aphena Pharma Solutions - Tennessee, LLC | e73d37f8-8a28-4d93-9529-fd1e2c84228a | 2021-08-17 | Boxed warning, Warnings, Adverse reactions | WARFARIN SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0832-1211 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0832-1212 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0832-1213 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0832-1214 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0832-1215 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0832-1216 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0832-1217 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0832-1218 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 0832-1219 | Jantoven | Warfarin Sodium | Upsher-Smith Laboratories, LLC | ANDA | Current |
| 55154-5618 | Jantoven | Warfarin Sodium | Cardinal Health | ANDA | Current |
| 55154-5619 | Jantoven | Warfarin Sodium | Cardinal Health | ANDA | Current |
| 55154-5620 | Jantoven | Warfarin Sodium | Cardinal Health | ANDA | Current |
| 55154-5621 | Jantoven | Warfarin Sodium | Cardinal Health | ANDA | Current |